IL159521A0 - Tricyclic pyridines for use in treatment of conditions mediated by crf - Google Patents
Tricyclic pyridines for use in treatment of conditions mediated by crfInfo
- Publication number
- IL159521A0 IL159521A0 IL15952102A IL15952102A IL159521A0 IL 159521 A0 IL159521 A0 IL 159521A0 IL 15952102 A IL15952102 A IL 15952102A IL 15952102 A IL15952102 A IL 15952102A IL 159521 A0 IL159521 A0 IL 159521A0
- Authority
- IL
- Israel
- Prior art keywords
- crf
- treatment
- conditions mediated
- tricyclic
- pyridines
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- External Artificial Organs (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0117395.4A GB0117395D0 (en) | 2001-07-17 | 2001-07-17 | Chemical compounds |
PCT/US2002/022394 WO2003008414A1 (en) | 2001-07-17 | 2002-07-15 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159521A0 true IL159521A0 (en) | 2004-06-01 |
Family
ID=9918654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15952102A IL159521A0 (en) | 2001-07-17 | 2002-07-15 | Tricyclic pyridines for use in treatment of conditions mediated by crf |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1425281B1 (no) |
JP (1) | JP2004537555A (no) |
KR (1) | KR20040027880A (no) |
CN (1) | CN1541217A (no) |
AT (1) | ATE316972T1 (no) |
AU (1) | AU2002354916B2 (no) |
BR (1) | BR0211220A (no) |
CA (1) | CA2452009A1 (no) |
DE (1) | DE60209014T2 (no) |
ES (1) | ES2256506T3 (no) |
GB (1) | GB0117395D0 (no) |
HU (1) | HUP0400460A2 (no) |
IL (1) | IL159521A0 (no) |
MX (1) | MXPA04000492A (no) |
NO (1) | NO20040203L (no) |
NZ (1) | NZ530508A (no) |
PL (1) | PL367965A1 (no) |
RU (1) | RU2004104464A (no) |
WO (1) | WO2003008414A1 (no) |
ZA (1) | ZA200309942B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002087573A1 (en) | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Crf receptor antagonists |
US7446108B2 (en) | 2001-05-21 | 2008-11-04 | Neurocrine, Inc. | Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists |
EP2002836B1 (en) * | 2007-05-31 | 2010-10-20 | Nerviano Medical Sciences S.r.l. | Cyclocondensed azaindoles active as kinase inhibitors |
PT2440558E (pt) | 2009-06-08 | 2015-08-27 | Takeda Pharmaceutical | Compostos de dihidropirrolonaftirridinona como inibidores de jak |
RU2498986C2 (ru) * | 2011-07-20 | 2013-11-20 | Учреждение Российской Академии Наук Институт Проблем Химической Физики Ран (Ипхф Ран) | ТЕТРАЦИАНОЗАМЕЩЕННЫЕ 1,4,9b-ТРИАЗАФЕНАЛЕНЫ И СПОСОБ ИХ ПОЛУЧЕНИЯ |
CN106279011A (zh) * | 2016-08-16 | 2017-01-04 | 成都百事兴科技实业有限公司 | 一种2,4‑二羟基‑6‑甲基烟酸乙酯的制备方法 |
KR102462991B1 (ko) * | 2020-11-02 | 2022-11-04 | 한국해양과학기술원 | 남극-유래 진균 균주 아크레모늄(Acremonium sp.) SF-7394에서 분리한 화합물 및 이를 포함하는 항염증, 항암 또는 항당뇨용 조성물 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4605642A (en) * | 1984-02-23 | 1986-08-12 | The Salk Institute For Biological Studies | CRF antagonists |
PT1129096E (pt) * | 1998-11-12 | 2003-09-30 | Neurocrine Biosciences Inc | Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos |
JP2002529465A (ja) * | 1998-11-12 | 2002-09-10 | ニューロクライン バイオサイエンシーズ, インコーポレイテッド | Crfレセプターアンタゴニストおよびcrfレセプターアンタゴニストに関する方法 |
-
2001
- 2001-07-17 GB GBGB0117395.4A patent/GB0117395D0/en not_active Ceased
-
2002
- 2002-07-15 BR BR0211220-5A patent/BR0211220A/pt not_active IP Right Cessation
- 2002-07-15 AT AT02752340T patent/ATE316972T1/de not_active IP Right Cessation
- 2002-07-15 MX MXPA04000492A patent/MXPA04000492A/es active IP Right Grant
- 2002-07-15 DE DE60209014T patent/DE60209014T2/de not_active Expired - Fee Related
- 2002-07-15 EP EP02752340A patent/EP1425281B1/en not_active Expired - Lifetime
- 2002-07-15 NZ NZ530508A patent/NZ530508A/en unknown
- 2002-07-15 CA CA002452009A patent/CA2452009A1/en not_active Abandoned
- 2002-07-15 PL PL02367965A patent/PL367965A1/xx not_active Application Discontinuation
- 2002-07-15 CN CNA02815746XA patent/CN1541217A/zh active Pending
- 2002-07-15 AU AU2002354916A patent/AU2002354916B2/en not_active Ceased
- 2002-07-15 IL IL15952102A patent/IL159521A0/xx unknown
- 2002-07-15 JP JP2003513973A patent/JP2004537555A/ja active Pending
- 2002-07-15 HU HU0400460A patent/HUP0400460A2/hu unknown
- 2002-07-15 RU RU2004104464/04A patent/RU2004104464A/ru not_active Application Discontinuation
- 2002-07-15 WO PCT/US2002/022394 patent/WO2003008414A1/en active IP Right Grant
- 2002-07-15 ES ES02752340T patent/ES2256506T3/es not_active Expired - Lifetime
- 2002-07-15 KR KR10-2004-7000714A patent/KR20040027880A/ko not_active Application Discontinuation
-
2003
- 2003-12-23 ZA ZA200309942A patent/ZA200309942B/xx unknown
-
2004
- 2004-01-16 NO NO20040203A patent/NO20040203L/no unknown
Also Published As
Publication number | Publication date |
---|---|
NO20040203L (no) | 2004-03-16 |
PL367965A1 (en) | 2005-03-07 |
AU2002354916B2 (en) | 2006-10-19 |
DE60209014T2 (de) | 2006-07-13 |
CN1541217A (zh) | 2004-10-27 |
EP1425281B1 (en) | 2006-02-01 |
NZ530508A (en) | 2005-11-25 |
GB0117395D0 (en) | 2001-09-05 |
CA2452009A1 (en) | 2003-01-30 |
DE60209014D1 (de) | 2006-04-13 |
EP1425281A1 (en) | 2004-06-09 |
KR20040027880A (ko) | 2004-04-01 |
BR0211220A (pt) | 2004-07-13 |
HUP0400460A2 (hu) | 2005-01-28 |
WO2003008414A1 (en) | 2003-01-30 |
ZA200309942B (en) | 2004-05-25 |
JP2004537555A (ja) | 2004-12-16 |
MXPA04000492A (es) | 2005-03-07 |
ATE316972T1 (de) | 2006-02-15 |
ES2256506T3 (es) | 2006-07-16 |
RU2004104464A (ru) | 2005-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069169A1 (en) | Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors | |
MXPA02012033A (es) | Derivados de 2-aminocarbonil-9h-purina. | |
TW200602036A (en) | Diphenylazetidone derivates | |
WO2006011050A3 (en) | Pyridine derivatives | |
GB0121621D0 (en) | Chemical compounds | |
TNSN05252A1 (en) | Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders : process for their preparation and pharmaceutical compositions containing them | |
MXPA02007942A (es) | Derivados de pirrolopirimidinona, procesos de preparacion y uso. | |
WO2001064639A3 (en) | Pde iv inhibiting amides, compositions and pharmaceutical use | |
MY139446A (en) | Novel quinoline derivatives | |
IL158667A0 (en) | Imidazo [1,2-a] pyridine derivatives for the prophylaxis and treatment of herpes viral infections | |
MXPA04000814A (es) | Derivados de 2h-piridazina-3-ona novedosos, composiciones farmaceuticas que contienen a los mismos y un procedimiento para la preparacion del ingrediente activo. | |
CY2466B1 (en) | Phenyl dihydrobenzofuranes. | |
DE602004005960D1 (de) | Heteroaryl-substituierte pyrrolä2, 3- büpyridin-derivate als crf-rezeptor-antagonisten | |
WO2003008412A3 (en) | Hetero-bicyclic crf antagonists | |
IL159521A0 (en) | Tricyclic pyridines for use in treatment of conditions mediated by crf | |
MXPA04005157A (es) | Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimiento celular anormal. | |
DE60226971D1 (de) | Corticotropinfreisetzungsfaktor antagonisten | |
SG146685A1 (en) | Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
YU82302A (sh) | Derivati 2-aminokarbonil-9h-purina | |
UA85201C2 (ru) | Производные дифенилацетидинона, которые являются ингибиторами абсорбции холестерола, способ их получения, фармацевтическая композиция на их основе | |
AP2002002492A0 (en) | Hygromycin a prodrugs. | |
MY135855A (en) | "pyrrolopyrimidinone derivatives, process of preparation and use" |